Upper respiratory illnesses, such as the common cold and flu, have a significant impact on our daily lives. According to the Centers for Disease Control and Prevention (CDC), common colds are the number one reason for the most missed days at school and work. Millions of cases are reported each year in the United States alone, with adults usually catching 2-3 colds a year, while children tending to experience even more frequent bouts.
Although less common, influenza is a much more serious illness. The CDC estimates that 3-11% of the U.S. population gets hit by the flu every year, resulting in hospitalizations and deaths.
To combat these upper respiratory illnesses naturally, a potential solution may be closer than you think: BLIS K12™. This strain of bacteria, scientifically known as Streptococcus salivarius K12, naturally resides in the mouth and throat, offering potential benefits in supporting the immune system. In this article, we will explore the key benefits of BLIS K12™ in fighting upper respiratory illnesses and its mechanism of action.
Causes, Symptoms, and Treatment of Upper Respiratory Illness
To better understand the significance of BLIS K12™ in combating upper respiratory illnesses, let’s briefly touch upon their causes, symptoms, and treatment.
Upper respiratory illnesses are primarily caused by viruses or bacteria that infect the nose, throat, sinuses, and upper airways. These infections spread through respiratory droplets released when an infected person talks, coughs, or sneezes. Symptoms often include nasal congestion, sore throat, cough, fever, and body aches. Treatment generally involves symptom management with over-the-counter medications, rest, and staying hydrated. Antibiotics may be prescribed if the infection is bacterial in nature.
BLIS K12™ – A Natural Solution for fighting URTIs
Numerous studies with both children and adults have shown the potential of BLIS K12™ in reducing the risk and severity of upper respiratory illnesses.
BLIS K12™ offers a natural approach to combatting upper respiratory illnesses through three key mechanisms of action:
- Colonization and competitive exclusion: BLIS K12™ colonizes the upper respiratory tract, effectively crowding out harmful bacteria by competing for binding sites. This competitive exclusion helps maintain a balanced microbial environment.
- Antimicrobial inhibition: BLIS K12™ produces antimicrobial peptides known as BLIS, which actively target and inhibit the growth of a broad range of pathogens that can cause upper respiratory infections.
- Stimulates an Immune Response: In addition to fighting off bacteria before it can take hold, BLIS K12™ has been found to stimulate the production of interferon gamma (IFN-γ), a crucial cytokine involved in the immune response to viral upper respiratory tract infections. IFN-γ plays a role in activating other immune cells and boosting the immune response, helping to eliminate the invading pathogens and prevent further infection.
Summary
BLIS K12™ presents a natural alternative for promoting oral health and fighting upper respiratory illnesses. Its colonization, competitive exclusion, antimicrobial inhibition, and immune-stimulating properties make it a promising choice for immune health support. Multiple studies have demonstrated its effectiveness in reducing the recurrence and severity of viral upper respiratory tract infections.
To learn more, read our whitepaper How BLIS K12™ Stimulates an Immune Response in Times of High Need. To explore more opportunities with BLIS K12™ get in touch:
